1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Medical Oncology

• Publication date

  2015-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-015-0603-1PMID 25895597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis

  2015cited by this paper
• Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis

  2015cited by this paper
• Magnetic resonance imaging in breast cancer: A literature review and future perspectives.

  2014cited by this paper
• Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis

  2014cited by this paper
• Magnetic resonance spectroscopy of the breast: current status.

  2013cited by this paper
• Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing breast tumors

  2013cited by this paper
• Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis.

  2013cited by this paper
• Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.

  2013cited by this paper
• 3.0 T proton magnetic resonance spectroscopy of the liver: quantification of choline.

  2013cited by this paper
• 1H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches

  2012cited by this paper
• Diagnostic Value of Breast Proton Magnetic Resonance Spectroscopy at 1.5T in Different Histopathological Types

  2012cited by this paper
• MR-spectroscopy at 1.5 tesla and 3 tesla. Useful? A systematic review and meta-analysis.

  2012cited by this paper
• Effects of Contrast Agent and Outer Volume Saturation Bands on Water Suppression and Shimming of Hepatic Single-Volume Proton MR Spectroscopy at 3.0T

  2012cited by this paper
• Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.

  2012cited by this paper
• Effects of contrast agent on water suppression and shimming of kidney single-volume proton MR spectroscopy at 3.0T.

  2010cited by this paper
• 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?

  2009cited by this paper
• Choline as a biomarker for cell proliferation: Do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers?

  2008cited by this paper
• Cancer survival in five continents: a worldwide population-based study (CONCORD).

  2008cited by this paper
• Proton MR spectroscopy in normal breasts between pre- and postmenopausal women: a preliminary study.

  2008cited by this paper
• Assessment of funnel plot asymmetry and publication bias in reproductive health meta-analyses: an analytic survey

  2007cited by this paper
• Cancer imaging with fluorine-18-labeled choline derivatives.

  2007cited by this paper
• Forest and funnel plots illustrated the calibration of a prognostic model: a descriptive study.

  2007cited by this paper
• Quantification of Choline-containing Compounds in Malignant Breast Tumors by 1H MR Spectroscopy Using Water as an Internal Reference at 1.5 T

  2006cited by this paper
• Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.

  2006cited by this paper
• Evaluation of spectral selected press sequence in breast lesion characterization.

  2006cited by this paper
• Forest plots and the interpretation of subgroups.

  2005cited by this paper
• Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: A feasibility study

  2005cited by this paper
• Detection of breast malignancy: diagnostic MR protocol for improved specificity.

  2004cited by this paper
• Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study

  2004cited by this paper
• Forest plots: data summaries at a glance.

  2004cited by this paper
• Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.

  2003cited by this paper
• In vivo quantification of choline compounds in the breast with 1H MR spectroscopy

  2003cited by this paper
• External standard method for the in vivo quantification of choline‐containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla

  2001cited by this paper

• Early prediction of pathologic complete response to neoadjuvant chemotherapy based on longitudinal total choline of MR spectroscopy in patients with breast cancer

  2026cites this paper
• Recognized and potential cancer biomarkers in ovarian MRS: Padé quantitative derivative shape estimation without fitting

  2025cites this paper
• In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla

  2024cites this paper
• Hyperpolarised 13C-MRI using 13C-pyruvate in breast cancer: A review.

  2023cites this paper
• Hyperpolarized Carbon-13 MRI in Breast Cancer

  2023cites this paper
• Assessment and Response to Neoadjuvant Treatments in Breast Cancer: Current Practice, Response Monitoring, Future Approaches and Perspectives.

  2023cites this paper
• Diagnostic accuracy of diffusion weighted imaging compared to magnetic resonance spectroscopy in differentiation of benign and malignant breast lesions: A systematic review and meta-analysis.

  2023cites this paper
• Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism

  2022cites this paper
• The use of hyperpolarised 13C-MRI in clinical body imaging to probe cancer metabolism

  2021cites this paper
• Imaging biomarkers for evaluating tumor response: RECIST and beyond

  2021cites this paper
• In vivo MR spectroscopy for breast cancer diagnosis

  2019cites this paper
• Advanced approaches to imaging primary breast cancer: an update

  2019cites this paper
• Changes in total choline concentration in the breast of healthy fertile young women in relation to menstrual cycle or use of oral contraceptives: a 3-T 1H-MRS study

  2018cites this paper
• Clinical applications of in vivo magnetic resonance spectroscopy in oncology

  2018cites this paper
• Breast Tissue Metabolism by Magnetic Resonance Spectroscopy

  2017cites this paper
• Magnetic Resonance Spectroscopy and its Clinical Applications: A Review.

  2017cites this paper
• Robust identification of the cancer biomarker phosphocholine through partitioned envelopes in noisy magnetic resonance spectroscopic data by the non-parametric fast Padé transform

  2017cites this paper
• Visualizing hidden components of envelopes non-parametrically in magnetic resonance spectroscopy: Phosphocholine, a breast cancer biomarker

  2017cites this paper
• Clinical Breast MR Using MRS or DWI: Who Is the Winner?

  2016influential citation